Share on your social networks:
2,000 students from four universities in Bucharest – “Carol Davila” University of Medicine and Pharmacy, University of Bucharest, University of Agronomic Sciences and Veterinary Medicine and Polytechnic University – can be tested for free with rapid tests for hepatitis B, hepatitis C and HIV until the end of the year, as part of the “Simply Test” campaign, organized by the Society of Infectious Diseases and HIV/AIDS in partnership with the Bucharest Hospitals and Medical Services Administration (ASSMB).
The main objectives of the campaign are the early detection of hepatitis B, C and HIV infections, to facilitate rapid access to treatment and limit transmission, as well as to raise awareness among students.
The campaign is carried out with the direct support of the medical staff from the university medical offices of the ASSMB School Medicine Network, which operates within the mentioned universities.
“Infections with hepatitis B, hepatitis C and HIV viruses produce chronic diseases that, undiagnosed and untreated in time, can lead to the spread of these infections to loved ones, chronic diseases, suffering and even death. What we want from this project is to convey correct, up-to-date information to students, which will make them understand how high the risk of infection with these viruses is. The fact that we are also able to screen for early detection of potential infections is more than welcome.” says Dr. Sorin Petrea, president of the Society of Infectious Diseases and HIV/AIDS.
“I am glad that together we managed to put together this large and at the same time extremely important education campaign for the health of students in Bucharest. Educating the public about the importance of testing and promoting access to testing are essential measures to reduce the incidence of these infections. ASSMB provides the necessary medical and sanitary personnel for this activity which takes place within the university medical offices.” said Oana Sivache, ASSMB General Director.
Human immunodeficiency virus (HIV) attack the immune system. HIV destroys white blood cells, weakening immunity against opportunistic infections such as tuberculosis and fungal infections, severe bacterial infections and some cancers.
WHO recommends that everyone who may be at risk of HIV infection should have access to testing, and people diagnosed with HIV should be given access to antiretroviral treatment as soon as possible after diagnosis and should be monitored regularly to prevent transmission .
38.4 million people were infected with HIV globally in 2021, of whom approximately 1.5 million became infected that year. Worldwide, 650,000 people died of HIV-related causes in 2021.
Hepatitis B is a chronic liver condition caused by the hepatitis B virus, with a high risk of death if it progresses to cirrhosis or liver cancer.
The disease is contagious, and the virus is most commonly transmitted from mother to child during pregnancy and childbirth, as well as through contact with blood or other body fluids during sexual intercourse with an infected partner, through unsafe injections or exposure to instruments sharp
296 million people were living with chronic hepatitis B infection in 2019 worldwide, and every year 1.5 million new cases of infection occur, WHO estimates. 820,000 people died in 2019 from hepatitis B, mainly from cirrhosis and liver cancer.
Hepatitis C is an inflammation of the liver caused by the hepatitis C virus. The virus can cause both acute and chronic hepatitis, ranging in severity from mild to severe, including liver cirrhosis and cancer.
The hepatitis C virus is transmitted through blood, and most infections occur from exposure to unsafe injections, blood transfusions or other unsafe medical care, injection drug use, and sexual contact.
Globally, an estimated 58 million people have hepatitis C, of which 3.2 million are children and adolescents. 1.5 million new cases of infection occur annually. 290,000 people died in 2019 from hepatitis C, mostly from cirrhosis and liver cancer.
Hepatitis C infection can remain asymptomatic for decades after infection, so most patients are diagnosed late, after the onset of serious liver damage. Antiviral drugs can cure up to 95% of people with hepatitis C infection, but access to diagnosis and treatment is limited.
Continue Reading
2023-10-28 08:12:12
#Students #universities #Bucharest #tested #hepatitis #hepatitis #HIV #free
/https://i.s3.glbimg.com/v1/AUTH_bc8228b6673f488aa253bbcb03c80ec5/internal_photos/bs/2023/H/o/egP1bHSoWNimFSFN3ttA/821221183.jpg "Atlético-MG Defeats Fluminense 2-0 in Brasileirão 2023: Coach Fernando Diniz Analyzes Match and Discusses Preparation for Libertadores Final")
